Prospective Evaluation of Lung Ultrasound For Preterm Infants

Prospective Evaluation of Lung Ultrasound For Preterm Infants - Preemie-LUS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022568

Enrollment

150

Registered

2026-01-13

Start date

2021-07-21

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

P22.0

Interventions

Group 1: Preterm Infants (birthweight < 1500g) get lung ultrasound during resuscitation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Preterm infants birthweight < 1500 grams

Exclusion criteria

Exclusion criteria: thoracic malformations perinatal pneumothorax, severe pleural effusions

Design outcomes

Primary

Measure	Time frame
Assoziation of a lung ultrasound score (LUSS) with the need for surfactant therapy (one or multiple doses Generating of ROC curves of the Lungs ultrasound score to determine the need for surfactant therapy	—

Secondary

Measure	Time frame
- Association of LUSS 2h after first surfactant with need for repetitive doses - Association of LUSS with the need for invasive ventilation, CPAP, noninvasive ventilation - Comparison of LUSS at 2h of life (+/- 30min) postnatal day 3, 7 (+/- 1 day), after that weekly between infants that develop bronchopulmonary dysplasia versus infants without	—

Countries

Germany

Contacts

Public ContactRichard Biedermann

Universitätsklinikum Jena

richard.biedermann@med.uni-jena.de+4936419329631

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026